Mission Bio is a startup company based in San Francisco. We have developed the Tapestri Platform which unlocks the ground truth of cancer through response, relapse, and remission, providing true single-cell multi-omics. As the first and only platform to analyze genotype and phenotype simultaneously in single cells, the Tapestri Platform can help unravel the inherent complexity of cancer.
Tapestri enables accurate characterization of your cell and gene therapy candidates for safer and more effective therapeutic strategies. Furthermore, we partner with pharma and biopharma companies across advanced therapy development programs to implement proven single-cell multi-omics capabilities into discovery, translational, and clinical research efforts. Learn more about our Pharma Assay Development services.